- Home
- Life Sciences
- Pharmaceutical
- Pathology
- Pathology Analysis & Statistics, February 2013 (p10)
Talk to Robyn
(866) 682 9815
Search inside this page
Top countries
- United States (3 964)
- World (47 560)
- Japan (2 638)
- France (2 545)
- Germany (2 536)
-
- Spain (2 520)
- United Kingdom (2 502)
- Europe (548)
- Italy (2 531)
- China (2 438)
- India (2 392)
- Canada (2 196)
- Australia (2 157)
- Sweden (2 019)
- Denmark (2 010)
- South Korea (2 355)
- Norway (2 006)
- Singapore (2 167)
- Switzerland (2 053)
- Indonesia (2 294)
Publication dates
Publishers
- Global Data (1 525)
- Global Markets Direct (1 838)
- Bioseeker (243)
- Euromonitor International (26)
- BCC Research (41)
-
- Ibisworld (8)
- Daedal Research (2)
- Firstword Pharma (7)
- GBI Research (41)
- KnowMade (2)
- World Market Intelligence Ltd (18)
- Asianet-Pakistan (4)
- Currentpartnering (97)
- Global Industry Analysts (1)
- International Market Analysis Research and Consult (11)
- La Merie Publishing (31)
- MarketLine (41)
- Transparency Market Research (1)
- TriMark Publications (7)
- Business Monitor International (401 825)
- Datamonitor (316)
- Life Science Analytics (LSA) (61)
- Global Research & Data Services (55)
- ICD Research (47)
- Frost & Sullivan (44)
- Timely Data Resources Inc. (41)
- Visiongain (32)
- Global Industry Analyst (28)
- Espicom Business Intelligence (27)
- Business Review (23)
- ABMRG (22)
- The Assessment Group (19)
- Kalorama Information (17)
- SCRIP Insights (17)
- Koncept Analytics (15)
- Asia Market Information & Development Company (14)
- CHI Insight Pharma Reports (14)
- Apollo Managed Care Consultants (13)
- Infiniti Research Limited (9)
- Sociable Pharma (9)
- IData Research, Inc. (9)
- Grey House Publishing (7)
- RNCOS (6)
- BioPharm Reports (5)
- MarketsandMarkets (5)
- Venture Planning Group (5)
- Aruvian's R'search (4)
- Freedonia (4)
- Canadean Ltd (3)
- Netscribes (India) Pvt. Ltd. (3)
- Renub Research (3)
- Arrowhead (2)
- France Innovation Scientifique et Transfert (2)
- Greystone Research Associates (2)
- Packaged Facts (2)
- Urch Publishing (2)
- Barnes Reports (1)
- Cygnus Business Consulting and Research (1)
- Ken Research Private (1)
- PMR Ltd. (1)
- Red Mountain Insights (1)
- Research In China (1)
- VacZine Analytics Group Of Assay Advantage Ltd (1)
- Verdict Research Ltd (1)
- WinterGreen Research (1)
- Zzz FACT Research (1)
All regions
-
- Algeria (2 248)
- Angola (2 320)
- Benin (2 312)
- Botswana (2 225)
- Burkina Faso (2 294)
- Burundi (2 306)
- Cameroon (2 318)
- Cape Verde (2 243)
- Central African Republic (106)
- Chad (2 313)
- Comoros (2 099)
- Congo, Democratic Republic Of (2 505)
- Djibouti (2 289)
- Egypt (2 338)
- Equatorial Guinea (2 292)
- Eritrea (2 259)
- Ethiopia (2 297)
- Gabon (2 269)
- Gambia (2 277)
- Ghana (2 321)
- Guinea (6 871)
- Guinea Bissau (2 303)
- Kenya (2 294)
- Lesotho (2 130)
- Liberia (2 210)
- Libyan Arab Jamahiriya (2 235)
- Madagascar (2 268)
- Malawi (2 309)
- Mali (2 318)
- Mauritania (2 262)
- Mauritius (2 206)
- Morocco (2 311)
- Mozambique (2 290)
- Namibia (2 221)
- Niger (2 318)
- Nigeria (2 327)
- Rwanda (2 281)
- Sao Tome and Principe (1 956)
- Senegal (2 315)
- Seychelles (2 063)
- Sierra Leone (2 307)
- Somalia (2 231)
- South Africa (2 267)
- Sudan (2 336)
- Swaziland (2 206)
- Tanzania (2 290)
- Togo (2 309)
- Tunisia (2 237)
- Uganda (2 320)
- Zambia (2 289)
- Zimbabwe (2 288)
-
- Afghanistan (2 321)
- Armenia (2 178)
- Azerbaijan (2 186)
- Bahrain (2 030)
- Bangladesh (2 288)
- Bhutan (2 207)
- Brunei Darussalam (2 078)
- Cambodia (2 300)
- China (2 438)
- Georgia (2 084)
- India (2 392)
- Indonesia (2 294)
- Iran (2 223)
- Iraq (2 315)
- Israel (2 034)
- Japan (2 638)
- Jordan (2 146)
- Kazakhstan (2 118)
- Kuwait (2 116)
- Kyrgyz Republic (kyrgyzstan) (2 187)
- Laos (2 295)
- Lebanon (1 553)
- Malaysia (2 290)
- Maldives (2 199)
- Mongolia (99)
- Myanmar (2 260)
- Nepal (2 280)
- North Korea (119)
- Oman (2 189)
- Pakistan (2 300)
- Philippines (2 300)
- Qatar (2 012)
- Saudi Arabia (2 234)
- Singapore (2 167)
- South Korea (2 355)
- Sri Lanka (2 254)
- Syrian Arab Republic (2 188)
- Taiwan (19)
- Tajikistan (2 163)
- Thailand (2 292)
- Turkey (5)
- Turkmenistan (98)
- United Arab Emirates (2 142)
- Uzbekistan (2 189)
- Vietnam (2 311)
- Yemen (2 334)
-
- Albania (2 040)
- Andorra (1 425)
- Austria (2 030)
- Belarus (2 055)
- Belgium (2 052)
- Bosnia and Herzegovina (2 028)
- Bulgaria (2 053)
- Croatia (2 006)
- Cyprus (1 986)
- Czech Republic (2 008)
- Denmark (2 010)
- Estonia (1 966)
- Finland (1 993)
- France (2 545)
- Germany (2 536)
- Greece (2 087)
- Hungary (2 039)
- Iceland (1 904)
- Ireland (2 032)
- Italy (2 531)
- Latvia (2 017)
- Lithuania (2 087)
- Luxembourg (1 932)
- Macedonia (91)
- Malta (1 990)
- Moldova, Republic Of (2 023)
- Monaco (1 268)
- Netherlands (2 052)
- Norway (2 006)
- Poland (2 080)
- Portugal (2 110)
- Romania (2 068)
- Russian Federation (2 148)
- San Marino (1 114)
- Serbia and Montenegro (2 060)
- Slovakia (slovak Republic) (2 045)
- Slovenia (1 978)
- Spain (2 520)
- Sweden (2 019)
- Switzerland (2 053)
- Ukraine (2 096)
- United Kingdom (2 502)
-
- Antigua and Barbuda (2 061)
- Bahamas (2 105)
- Barbados (2 101)
- Belize (2 122)
- Canada (2 196)
- Costa Rica (2 185)
- Cuba (2 211)
- Dominica (4 113)
- Dominican Republic (2 285)
- El Salvador (2 220)
- Grenada (2 018)
- Guatemala (2 373)
- Haiti (2 275)
- Honduras (2 317)
- Jamaica (2 169)
- Mexico (2 379)
- Nicaragua (2 265)
- Panama (1 561)
- Saint Kitts & Nevis (1 889)
- Saint Lucia (2 227)
- United States (3 964)
-
- Argentina (2 263)
- Australia (2 157)
- Brazil (2 439)
- Canada (2 196)
- China (2 438)
- France (2 545)
- Germany (2 536)
- India (2 392)
- Indonesia (2 294)
- Italy (2 531)
- Japan (2 638)
- Mexico (2 379)
- Russian Federation (2 148)
- Saudi Arabia (2 234)
- South Africa (2 267)
- South Korea (2 355)
- Turkey (5)
- United Kingdom (2 502)
- United States (3 964)
-
- Australia (2 157)
- Austria (2 030)
- Belgium (2 052)
- Canada (2 196)
- Chile (2 214)
- Czech Republic (2 008)
- Denmark (2 010)
- Estonia (1 966)
- Finland (1 993)
- France (2 545)
- Germany (2 536)
- Greece (2 087)
- Hungary (2 039)
- Iceland (1 904)
- Ireland (2 032)
- Israel (2 034)
- Italy (2 531)
- Japan (2 638)
- Luxembourg (1 932)
- Mexico (2 379)
- Netherlands (2 052)
- New Zealand (1 942)
- Norway (2 006)
- Poland (2 080)
- Portugal (2 110)
- Slovenia (1 978)
- South Korea (2 355)
- Spain (2 520)
- Sweden (2 019)
- Switzerland (2 053)
- Turkey (5)
- United Kingdom (2 502)
- United States (3 964)
data types
Free Market Research Guides to Download
Pathology Analysis & Statistics, February 2013 (p10)
You might be interested in: cancer, breast cancer, prostate cancer, more »
» Purchase Premium Reports
271-310 of about 4 800 reports
Pathology in United States: Autism - Pipeline Review, H1 2012
- $ 2 000
- Industry report
- February 2013
- by Global Markets Direct
This report provides data on the therapeutic development for Autism, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in ...
- Industries : Pathology
- Countries : World
Functional (Non Ulcer) Dyspepsia - Pipeline Review, H1 2013
- $ 2 000
- Industry report
- February 2013
- by Global Markets Direct
Functional (Non Ulcer) Dyspepsia - Pipeline Review, H1 2013 Summary Global Markets Direct's, 'Functional (Non Ulcer) Dyspepsia - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic ...
- Industries : Pathology
- Countries : World
World Pathology: Acute Heart Failure - Pipeline Review, H1 2012
- $ 2 000
- Industry report
- February 2013
- by Global Markets Direct
This report provides data on the therapeutic development for Acute Heart Failure, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players ...
- Industries : Pathology
- Countries : World, United States
Anaplastic Thyroid Cancer - Pipeline Review, H1 2013
- $ 2 000
- Industry report
- February 2013
- by Global Markets Direct
Anaplastic Thyroid Cancer - Pipeline Review, H1 2013 Summary Global Markets Direct's, 'Anaplastic Thyroid Cancer - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. ...
- Industries : Pathology
- Countries : World, Israel
World Pathology: Premature Ejaculation - Pipeline Review, H1 2012
- $ 2 000
- Industry report
- February 2013
- by Global Markets Direct
This report provides data on the therapeutic development for Premature Ejaculation, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players ...
- Industries : Pathology
- Countries : World
Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2013
- $ 2 000
- Industry report
- February 2013
- by Global Markets Direct
Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2013 Summary Global Markets Direct's, 'Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2013', provides an overview ...
- Industries : Pathology
- Countries : World
World Pathology: Aspergillosis - Pipeline Review, H1 2012
- $ 2 000
- Industry report
- February 2013
- by Global Markets Direct
This report provides data on the therapeutic development for Aspergillosis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved ...
- Industries : Pathology
- Countries : World
Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) - Pipeline Review, H1 2013
- $ 2 000
- Industry report
- February 2013
- by Global Markets Direct
Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) - Pipeline Review, H1 2013 Summary Global Markets Direct's, 'Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) ...
- Industries : Pathology
- Countries : World
World Pathology: Pediatric Cancer - Pipeline Review, H1 2012
- $ 2 000
- Industry report
- February 2013
- by Global Markets Direct
This report provides data on the therapeutic development for Pediatric Cancer, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved ...
- Industries : Pathology
- Countries : World, United States
World Therapy: Rhinosinusitis - Pipeline Review, H1 2012
- $ 2 000
- Industry report
- February 2013
- by Global Markets Direct
This report provides data on the therapeutic development for Rhinosinusitis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved ...
- Industries : Pathology
- Countries : World, Canada
World Pathology: Periodontal Disease - Pipeline Review, H1 2012
- $ 2 000
- Industry report
- February 2013
- by Global Markets Direct
This report provides data on the therapeutic development for Periodontal Disease, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players ...
- Industries : Pathology
- Countries : World
World Pathology: Otitis Media - Pipeline Review, H1 2012
- $ 2 000
- Industry report
- February 2013
- by Global Markets Direct
This report provides data on the therapeutic development for Otitis Media, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved ...
- Industries : Pathology
- Countries : World, South Korea
World Pathology: Herpes Zoster (Shingles) ? Pipeline Review, H1 2012
- $ 2 000
- Industry report
- February 2013
- by Global Markets Direct
This report provides data on the therapeutic development for Herpes Zoster (Shingles), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players ...
- Industries : Pathology
- Countries : World
World Pathology: Spasticity - Pipeline Review, H1 2012
- $ 2 000
- Industry report
- February 2013
- by Global Markets Direct
This report provides data on the therapeutic development for Spasticity, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved ...
- Industries : Pathology
- Countries : World, Europe, United States
Pathology in United States: Fatty Liver Disease - Pipeline Review, H1 2012
- $ 2 000
- Industry report
- February 2013
- by Global Markets Direct
This report provides data on the therapeutic development for Fatty Liver Disease, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players ...
- Industries : Pathology
- Countries : United States, World
World Pathology: Bipolar Disorder (Manic Depression) ? Pipeline Review, H1 2012
- $ 2 000
- Industry report
- February 2013
- by Global Markets Direct
This report provides data on the therapeutic development for Bipolar Disorder (Manic Depression), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews ...
- Industries : Pathology
- Countries : World
World Pathology: Acute Coronary Syndrome - Pipeline Review, H1 2012
- $ 2 000
- Industry report
- February 2013
- by Global Markets Direct
This report provides data on the therapeutic development for Acute Coronary Syndrome, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players ...
- Industries : Pathology
- Countries : World
World Pathology: Gouty Arthritis (Gout) ? Pipeline Review, H1 2012
- $ 2 000
- Industry report
- February 2013
- by Global Markets Direct
This report provides data on the therapeutic development for Gouty Arthritis (Gout), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players ...
- Industries : Pathology
- Countries : World
Bone Metastasis - Pipeline Review, H1 2013
- $ 2 000
- Industry report
- February 2013
- by Global Markets Direct
Bone Metastasis - Pipeline Review, H1 2013 Summary Global Markets Direct's, 'Bone Metastasis - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. This report provides ...
- Industries : Pathology
- Countries : World
Pathology in United States: Urinary Incontinence - Pipeline Review, H1 2012
- $ 2 000
- Industry report
- February 2013
- by Global Markets Direct
This report provides data on the therapeutic development for Urinary Incontinence, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players ...
- Industries : Pathology
- Countries : World
World Pathology: Acne And Related Disorders - Pipeline Review, H1 2012
- $ 2 000
- Industry report
- February 2013
- by Global Markets Direct
This report provides data on the therapeutic development for Acne And Related Disorders, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key ...
- Industries : Pathology
- Countries : World, United States
Pathology in United States: Benign Prostatic Hyperplasia - Pipeline Review, H1 2012
- $ 2 000
- Industry report
- February 2013
- by Global Markets Direct
This report provides data on the therapeutic development for Benign Prostatic Hyperplasia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key ...
- Industries : Pathology
- Countries : World
Lung Adenocarcinoma - Pipeline Review, H1 2013
- $ 2 000
- Industry report
- February 2013
- by Global Markets Direct
Lung Adenocarcinoma - Pipeline Review, H1 2013 Summary Global Markets Direct's, 'Lung Adenocarcinoma - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. This report ...
- Industries : Pathology
- Countries : World
World Pathology: Urinary Tract Infections - Pipeline Review, H1 2012
- $ 2 000
- Industry report
- February 2013
- by Global Markets Direct
This report provides data on the therapeutic development for Urinary Tract Infections, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players ...
- Industries : Pathology
- Countries : World
World Pathology: Celiac Disease - Pipeline Review, H1 2012
- $ 2 000
- Industry report
- February 2013
- by Global Markets Direct
This report provides data on the therapeutic development for Celiac Disease, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved ...
- Industries : Pathology
- Countries : World
Metastatic Prostate Cancer - Pipeline Review, H1 2013
- $ 2 000
- Industry report
- February 2013
- by Global Markets Direct
Metastatic Prostate Cancer - Pipeline Review, H1 2013 Summary Global Markets Direct's, 'Metastatic Prostate Cancer - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. ...
- Industries : Pathology
- Countries : World
Pathology in Denmark: Atrial Fibrillation - Pipeline Review, H1 2012
- $ 2 000
- Industry report
- February 2013
- by Global Markets Direct
This report provides data on the therapeutic development for Atrial Fibrillation, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players ...
- Industries : Pathology
- Countries : World, United States
World Pathology: Hemophilia B - Pipeline Review, H1 2012
- $ 2 000
- Industry report
- February 2013
- by Global Markets Direct
This report provides data on the therapeutic development for Hemophilia B, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved ...
- Industries : Pathology
- Countries : World, China
Leukemia Drug Pipeline Update 2013
- $ 2 249
- Industry report
- April 2013
- by Bioseeker
Leukemia includes a broad variety of histological separate disorders which make the leukemia market segmented. There are today 261 companies plus partners developing 344 leukemia drugs in 511 developmental ...
- Industries : Pathology
Melanoma Drug Pipeline Update 2013
- $ 2 249
- Industry report
- April 2013
- by Bioseeker
Melanoma comprises just 5% of all skin cancers but it is the most deadly. High unmet needs still persist for this tumor type and despite three decades of extensive R&D, five-year survival of advanced patients ...
- Industries : Pathology
Austria Peptic Ulcer Disease, 45-59 Yrs, Male, Dalys
- $ 250
- Industry data
- May 2013
Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research
- Industries : Pathology
- Countries : Austria
Norway Peptic Ulcer Disease, 45-59 Yrs, Male, Dalys
- $ 250
- Industry data
- May 2013
Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research
- Industries : Pathology
- Countries : Norway
Palau Post-traumatic Stress Disorder, 45-59 Yrs, Male, Dalys
- $ 250
- Industry data
- May 2013
Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research
- Industries : Pathology
- Countries : World
Iraq Prostate Cancer, 45-59 Yrs, Male, Dalys
- $ 250
- Industry data
- May 2013
Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research
- Industries : Pathology
- Countries : Iraq, World
Lesotho Post-traumatic Stress Disorder, 15-29 Yrs, Male, Dalys
- $ 250
- Industry data
- May 2013
Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research
- Industries : Pathology
- Countries : Lesotho
Papua New Guinea Schistosomiasis, Dalys
- $ 250
- Industry data
- May 2013
Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research
- Industries : Pathology
- Countries : Papua New Guinea, Guinea
Paraguay Prostate Cancer, 70+ Yrs, Male, Dalys
- $ 250
- Industry data
- May 2013
Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research
- Industries : Pathology
- Countries : Paraguay
Honduras Prostate Cancer, 70+ Yrs, Male, Dalys
- $ 250
- Industry data
- May 2013
Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research
- Industries : Pathology
- Countries : Honduras
Dominican Republic Post-traumatic Stress Disorder, 30-44 Yrs, Male, Dalys
- $ 250
- Industry data
- May 2013
Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research
- Industries : Pathology
- Countries : Dominican Republic, Dominica
Belgium Protein-energy Malnutrition, 70+ Yrs, Male, Dalys
- $ 250
- Industry data
- May 2013
Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research
- Industries : Pathology
- Countries : Belgium
» Download Public Reports
About 17 000 reports
Company Report: Pathology in The United States and Ireland for Year 2013
- Company report
- May 2013
- 5 pages
- by Corporation
... Involved, even indirectly, with an important therapeutic area that addresses the needs of millions of patients who suffer from respiratory disease is particularly meaningful to all of us at elan." Relvar ...
Pharmaceutical Business Analysis
May 2013U.s. Pharmaceutical Industry
May 2013The Swazi Pharmaceutical Industry
May 2013» Read our Company Profiles
About 200 CompaniesNovartis Inc.
SwitzerlandGlaxoSmithKline P.L.C.
United StatesGlaxoSmithKline PLC
United KingdomEli Lilly and Co.
United StatesLilly and Co.
United StatesReportlinker.com © Copyright 2013. All rights reserved.
